Antisense inhibition of amphiregulin expression reduces EGFR phosphorylation in transformed human breast epithelial cells

Anticancer Research

Volumn 30, Issue 6, 2010, Pages 2101-2106

  Ma, L ^a   Huet, E ^b   Serova, M ^c   Berthois, Y ^d   Calvo, F ^c   Mourah, S ^c   Menashi, S ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b CNRS EAC 7149 ^*  (France)

^c SAINT LOUIS HOSPITAL   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Amphiregulin; Breast cancer; EGFR; MMP 9

Indexed keywords

AMPHIREGULIN; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE B;

ANTISENSE THERAPY; ARTICLE; BREAST CANCER; CELL PROLIFERATION; CELL TRANSFORMATION; DNA SYNTHESIS INHIBITION; DRUG INHIBITION; ENZYME SYNTHESIS; EPITHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ZYMOGRAPHY;

ANTISENSE ELEMENTS (GENETICS); BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; EPIDERMAL GROWTH FACTOR; FEMALE; GLYCOPROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MATRIX METALLOPROTEINASE 9; PHOSPHORYLATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; TYROSINE;

EID: 77955061557     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Sainsbury JR, Farndon JR, Needham GK, Malcolm AJ and Harris AL: Epidermal growth factor receptor Status as predictor of early recurrence of and death from breast cancer. Lancet 1: 1398-1402, 1987. (Pubitemid 17078859)
2. Khazaie K, Schirrmacher V and Lichtner RB: EGF receptor in neoplasia and metastasis. Cancer Metastasis Rev 12: 255-274, 1993.
3. Agrawal A, Gutteridge E, Gee JM, Nicholson RI and Robertson JF: Overview of tyrosine kinase inhibitors in clinical breast cancer. Endocr Relat Cancer 12(Suppl 1): S135-144, 2005.
4. Paez JG, Janne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, Fujii Y, Eck MJ, Sellers WR, Johnson BE and Meyerson M: EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 304: 1497-1500, 2004.
5. Ferrer-Soler L, Vazquez-Martin A, Brunet J, Menendez JA, De Llorens R and Colomer R: An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa)-induced changes in the expression and nucleocytoplasmic trafficking of HER ligands. Int J Mol Med 20: 3-10, 2007.
6. Brown CL, Meise KS, Plowman GD, Coffey RJ and Dempsey PJ: Cell surface ectodomain cleavage of human amphiregulin precursor is sensitive to a metalloprotease inhibitor. Release of a predominant N-glycosylated 43-kDa soluble form. J Biol Chem 273: 17258-17268, 1998.
7. Inui S, Higashiyama S, Hashimoto K, Higashiyama M, Yoshikawa K and Taniguchi N: Possible role of coexpression of CD9 with membrane-anchored heparin-binding EGF-like growth factor and amphiregulin in cultured human keratinocyte growth. J Cell Physiol 171: 291-298, 1997.
8. Willmarth NE and Ethier SP: Autocrine and juxtacrine effects of amphiregulin on the proliferative, invasive, and migratory properties of normal and neoplastic human mammary epithelial cells. J Biol Chem 281: 37728-37737, 2006.
9. Sternlicht MD, Sunnarborg SW, Kouros-Mehr H, Yu Y, Lee DC and Werb Z: Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin. Development 132: 3923-3933, 2005.
10. Qi CF, Liscia DS, Normanno N, Merlo G, Johnson GR, Gullick WJ, Ciardiello F, Saeki T, Brandt R and Kim N: Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas. Br J Cancer 69: 903-910, 1994.
11. Li S, Plowman GD, Buckley SD and Shipley GD: Heparin inhibition of autonomous growth implicates amphiregulin as an autocrine growth factor for normal human mammary epithelial cells. J Cell Physiol 153: 103-111, 1992.
12. Berquin IM, Dziubinski ML, Nolan GP and Ethier SP: A functional screen for genes inducing epidermal growth factor autonomy of human mammary epithelial cells confirms the role of amphiregulin. Oncogene 20: 4019-4028, 2001.
13. Ma L, Gauville C, Berthois Y, Millot G, Johnson GR and Calvo F: Antisense expression for amphiregulin suppresses tumorigenicity of a transformed human breast epithelial cell line. Oncogene 18: 6513-6520, 1999.
14. Deryugina EI and Quigley JP: Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25: 9-34, 2006.
15. Freije JM, Balbin M, Pendas AM, Sanchez LM, Puente XS and Lopez-Otin C: Matrix metalloproteinases and tumor progression. Adv Exp Med Biol 532: 91-107, 2003.
16. Kondapaka SB, Fridman R and Reddy KB: Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells. Int J Cancer 70: 722-726, 1997. (Pubitemid 27158453)
17. Ocharoenrat P, Modjtahedi H, Rhys-Evans P, Court WJ, Box GM and Eccles SA: Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells. Cancer Res 60: 1121-1128, 2000. (Pubitemid 30129555)
18. Berthon P, Goubin G, Dutrillaux B, Degeorges A, Faille A, Gespach C and Calvo F: Single-steep transformation of human breast epithelial cells by SV40 large T oncogene. Int J Cancer 52: 92-97, 1992.
19. Ma L, Gauville C, Berthois Y, Degeorges A, Millot G, Martin PM and Calvo F: Role of epidermal growth factor receptor in tumor progression in transformed human mammary epithelial cells. Int J Cancer 78: 112-119, 1998.
20. Fridman R, Toth M, Pena D and Mobashery S: Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 55: 2548-2555, 1995.
21. Menashi S, Serova M, Ma L, Vignot S, Mourah S and Calvo F: Regulation of extracellular matrix metalloproteinase inducer and matrix metalloproteinase expression by amphiregulin in transformed human breast epithelial cells. Cancer Res 63: 7575-7580, 2003.
22. Giusti C, Desruisseau S, Ma L, Calvo F, Martin PM and Berthois Y: Transforming growth factor beta-1 and amphiregulin act in synergy to increase the production of urokinase-type plasminogen activator in transformed breast epithelial cells. Int J Cancer 105: 769-778, 2003.
23. Willmarth NE and Ethier SP: Amphiregulin as a novel target for breast cancer therapy. J Mammary Gland Biol Neoplasia 13: 171-179, 2008.